Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$29 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0552
D

Failure to Inform Residents of Psychotropic Medication Risks and Benefits

Middletown, Delaware Survey Completed on 01-30-2026

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that residents were informed of psychotropic medication side effects and the associated risks versus benefits, as required by facility policy. One resident with bipolar disorder, major depressive disorder (MDD), and anxiety had an intact cognition with a BIMS score of 14/15 and was receiving buspirone for anxiety, duloxetine for MDD, and risperidone for delusional disorder. Review of the electronic medical record (EMR) showed no documentation of consent or any risk-versus-benefit discussion regarding these psychotropic medications with the resident or a representative. In an interview, this resident stated she had been told what medications she was on but not about potential effects related to the medications. The DON confirmed there was no documentation specific to review of potential effects of psychotropic medications with the resident or representative, despite the policy requiring such education and documentation. Another resident, admitted and later readmitted with diagnoses including MDD and anxiety disorder, had an intact cognition with a BIMS score of 15/15 and was receiving buspirone for anxiety and duloxetine for depression. EMR review similarly revealed no documentation of consent or risk-versus-benefit review for these medications. In an interview, this resident reported not remembering any discussion with staff about medication effects and was unsure of what medications she was taking. The DON stated there was no documentation of any staff conversation with this resident regarding risks versus benefits for the medications. Review of the facility’s psychoactive medications policy, last reviewed on 01/13/26, showed that residents are to be educated on the benefits and potential risks of these drugs and that such education is to be documented in the medical record, which did not occur for these two residents.

Long-term care team reviewing survey readiness and plan of correction

We Help Long-Term Care Teams Stay Survey-Ready

We process and analyze inspection reports and plan of correction using AI to extract insights and trends so providers can improve care quality and stay ahead of compliance risks.

Discover our solutions:

An unhandled error has occurred. Reload 🗙